Trial NCT04478695

View at ClinicalTrials.gov 
Org. Study IDs: 20170646
Secondary IDs: KEYNOTE-613

Last trial update was posted on 2024-03-08

MeSH Interventions

Pembrolizumab

MeSH Conditions

Leukemia Leukemia, Myeloid Leukemia, Myeloid, Acute

Other Conditions

Relapsed or Refractory Acute Myeloid Leukemia

Stopping Reasons

Amgen Decision

Limitations And Caveats

This study was early terminated, leading to a small number of participants enrolled and analyzed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID